相关实验视频

Updated: Jul 12, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

新抗原疫苗的最新进展用于治疗非小细胞肺癌

Shu Su¹, Fungjun Chen¹, Mingyuan Xu¹

¹The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University and Clinical Cancer Institute of Nanjing University, Nanjing, China.

Thoracic cancer

|October 31, 2023

概括

新抗原疫苗和疗法有望改善非小细胞肺癌 (NSCLC) 免疫疗法,通过向特定瘤突变来补充编程细胞死亡蛋白1 (PD-1) 阻塞.

科学领域:

免疫学和瘤学
癌症治疗方法癌症治疗方法

背景情况:

编程细胞死亡蛋白1 (PD-1) 阻断疗法已经彻底改变了非小细胞肺癌 (NSCLC) 治疗.
治疗成功与高瘤突变负担和肺癌细胞免疫性有关.
对当前免疫疗法的耐药性需要新的方法来增强活性免疫反应.

研究的目的:

审查新抗原疫苗和针对癌症,特别是NSCLC的基于新抗原的治疗方法的进展.
讨论在NSCLC患者中新抗原的鉴定和相关突变.
探索改善NSCLC免疫疗法的疗效超越免疫检查点封锁的策略.

主要方法:

关于新抗原疫苗在癌症治疗中的当前文献的综述.
对基于新抗原的NSCLC疗法的临床前研究和早期临床试验的分析.
检查在NSCLC患者中新抗原鉴定方法.

主要成果:

新抗原是高度免疫的,是癌症免疫疗法的特定标.
新抗原疫苗和疗法在NSCLC的临床前和临床早期环境中显示出潜力.
最近的研究已经确定了在NSCLC中针对新抗原的候选突变.

结论:

新抗原向方法是增强NSCLC免疫疗法的有希望的策略.
这些策略,以及免疫检查点封锁,可以克服耐药性并提高治疗效率.
对NSCLC进行进一步的新抗原鉴定和治疗应用的研究是有必要的.

关键词:

免疫疗法免疫疗法肺癌是一种肺癌.新抗原是一种新抗原.疫苗疫苗疫苗疫苗

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...